PITUITARY ADENOMA APOPLEXY: PATHOPHYSIOLOGICAL MECHANISMS, CLINICAL HETEROGENEITY, DIAGNOSTIC PITFALLS, AND THERAPEUTIC OUTCOMES

Abstract

Pituitary adenoma apoplexy is an acute neuroendocrine condition caused by hemorrhage or infarction within a pituitary adenoma and is associated with significant morbidity and potential mortality. Despite advances in neuroimaging and endocrine diagnostics, this complication remains underrecognized due to its polymorphic clinical presentation and frequent diagnostic misinterpretation. The present article analyzes the pathophysiological basis of pituitary adenoma apoplexy, emphasizing vascular insufficiency, metabolic imbalance of adenomatous tissue, and precipitating systemic factors such as pregnancy and pharmacological interventions. Clinical variability is illustrated by cases involving both microadenomas and macroadenomas, hormonally active and inactive tumors, with particular attention to prolactinomas. Diagnostic challenges, including frequent confusion with cerebrovascular events and pregnancy-related conditions, are critically discussed. Therapeutic strategies ranging from conservative management to dopamine agonist therapy and surgical decompression are evaluated in the context of neurological and endocrine outcomes. The analysis demonstrates that, in selected cases, pituitary apoplexy may result in spontaneous tumor regression and partial or complete endocrine remission. Early recognition and interdisciplinary management are essential for optimizing prognosis and preventing long-term complications.